8-K: Current report filing
Published on July 15, 2008
SECURITIES
      AND EXCHANGE COMMISSION 
    Washington,
      D.C. 20549 
    FORM
      8-K
    CURRENT
      REPORT 
    PURSUANT
      TO SECTION 13 OR 15(d) OF 
    THE
      SECURITIES EXCHANGE ACT OF 1934 
    Date
      of
      Report (Date of earliest event reported): July 3, 2008
    SICLONE
      INDUSTRIES, INC. 
    (Exact
      name of registrant as specified in its charter) 
    | 
               Delaware 
             | 
            
               000-25809 
             | 
            
               87-0426999 
             | 
          
| 
               (State
                or Other Jurisdiction 
             | 
            
               (Commission
                File 
             | 
            
               (I.R.S.
                Employer 
             | 
          
| 
               of
                Incorporation) 
             | 
            
               Number) 
             | 
            
               Identification
                Number) 
             | 
          
1010
      N.
      Central Avenue, Suite 201, Glendale, CA 91202
    (Address
      of principal executive offices) (zip code) 
    (818)
      507-4617
    (Registrant's
      telephone number, including area code) 
    Copies
      to:
    Andrea
      Cataneo, Esq.
    Sichenzia
      Ross Friedman Ference LLP
    61
      Broadway
    New
      York,
      New York 10006
    Phone:
      (212) 930-9700
    Fax:
      (212) 930-9725
    (Former
      name or former address, if changed since last report)
    Check
      the
      appropriate box below if the Form 8-K filing is intended to simultaneously
      satisfy the filing obligation of the registrant under any of the following
      provisions (see General Instruction A.2. below):
    [
      ]
      Written communications pursuant to Rule 425 under the Securities Act (17 CFR
      230.425)
    [
      ]
      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)
    [
      ]
      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
      Act
      (17 CFR 240.14d-2(b))
    [
      ]
      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
      Act
      (17 CFR 240.13e-4(c))
    Item
      5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    
Effective
      July 3, 2008, the Company changed its name from Siclone Industries, Inc. to
      Apollo Medical Holdings, Inc. In addition, effective July 15, 2008, the
      Company's quotation symbol on the Over-the-Counter Bulletin Board was changed
      from SICL to AMEH. A copy of the Certificate of Ownership changing the Company's
      name to Apollo Medical Holdings, Inc. is attached hereto as Exhibit 3.1.
    Item
      9.01 Financial Statements and Exhibits
    (a)
      Financial statements of business acquired. 
    Not
      applicable. 
    (b)
      Pro forma financial information. 
    Not
      applicable. 
    
3.1 
    Certificate of Ownership
    1
        SIGNATURES
    Pursuant
      to the requirements of the Securities and Exchange Act of 1934, the registrant
      has duly caused this report to be signed on its behalf by the undersigned
      hereunto duly authorized. 
    | SICLONE INDUSTRIES, INC. | ||
| 
                 Dated:
                  July 15, 2008 
               | 
              
                 By:
                   
               | 
              
                 /s/
                  Warren Hosseinion 
               | 
            
| 
                 Name:
                   
               | 
              
                 Warren
                  Hosseinion 
               | 
            |
| 
                 Title: 
               | 
              
                 Chief
                  Executive Officer and 
               | 
            |
| 
                 Principal
                  Accounting Officer 
               | 
            ||
2